×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
熱門媒體
熱門媒體
(
最新
)
熱門媒體
(
最新
)
PD07-6: Could a single implant in the corpus cavernosum be sustainable?
702 觀看
PD06-6: The association between sarcopenia and postoperative outcomes after robotic assisted radical prostatectomy
702 觀看
PD09-5: The Effects of Cyproheptadine in Eliciting Natural Killer cell-mediated Immune Response in Bladder Cancer
701 觀看
(MP01-02) Testosterone breakthrough rates during androgen deprivation therapy for castration sensitive prostate cancer
700 觀看
NPD49: mCRPC with pulmonary metastases, low PSA, and elevated CEA, CA-125, CA-199, NSE, and CYFRA 21-1: a case report
699 觀看
PD01-3: Complication Analysis of Transurethral Resection of Prostate Under Different Types of Anesthesia: A Nationwide, Population-based Cohort Study
699 觀看
NDP45: Retrograde intrarenal surgery effectively treated a case of urolithiasis with unilateral ectopic kidney
697 觀看
PD06-5: Anastomotic urinary leakage after Retzius-sparing robot-assisted radical prostatectomy.
695 觀看
(MP1-05) Public Chinese Prostate Cancer Professional Series-3:Updated Treatment for non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
694 觀看
PD03-4: Risk factors and management of fournier's gangrene: An 18-year retrospective study
694 觀看
NDP29: Poorly differentiated urothelial carcinoma of the urachus: A case report
694 觀看
PD09-3: The incidence and multiplex nomogram for prediction of metachronous and synchronous upper tract urothelial cancer in patients with non-muscle invasive urinary bladder cancer
691 觀看
(MP3-05) High Incidence of Upgrading between Ureterorenoscopic Biopsy and Final Pathology in Upper Tract Urothelial Carcinoma: A Single Regional Hospital Experience
690 觀看
(MP1-02) Public Chinese Prostate Cancer Professional Series-3:Updated Treatment for metastatic Castration-Sensitive Prostate Cancer (mCSPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
689 觀看
PD02-3: Urinary Exfoliated Cells as a Potential Biomarker for Urothelial Carcinoma
689 觀看
NDP19: Aggressive prostate cancer mimicking urothelial carcinoma: A case report
688 觀看
NPD11: Primary neuroendocrine tumor (NET) of urachus: a case report
687 觀看
NPD55: Retroperitoneal fibrosis: A disease of multifactorial etiologies
687 觀看
PD02-1: Ferroptosis induction and glutathione peroxidase 4 suppression as mechanisms of Evodiamine's inhibition to high grade bladder cancer cell
687 觀看
NDP060: Enfortumab vedotin in treatment of advanced urothelial carcinoma: A case series and review of the literature
686 觀看
NDP17: Primary diffuse large B cell lymphoma (DLBCL) of the prostate presenting with repeated acute urine retention
685 觀看
(MP1-03) Public Chinese Prostate Cancer Professional Series-3:Updated Treatment for metastatic Castration-Resistant Prostate Cancer (mCRPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
684 觀看
NDP26: Paraneoplastic syndrome associated with urachal poorly differentiated urothelial carcinoma – a rare case report
684 觀看
(MP3-06) Real-world outcome of endoscopic laser ablation for upper urinary tract urothelial carcinoma
683 觀看
<
101
102
103
104
105
106
107
108
109
110
>
/ 127